Induction of the genes forCxcl9 andCxcl10 is dependent on IFN-γ but shows differential cellular expression in experimental autoimmune encephalomyelitis and by astrocytes and microgliain vitro-Reference-Cited by-同舟云学术

Induction of the genes forCxcl9 andCxcl10 is dependent on IFN-γ but shows differential cellular expression in experimental autoimmune encephalomyelitis and by astrocytes and microgliain vitro

Published:2007 Issue:16 Volume:55 Page:1728-1739
ISSN:0894-1491
Container-title:Glia
language:en
Short-container-title:Glia

Author:

Carter Sally L.,Müller Marcus,Manders Peter M.,Campbell Iain L.

Publisher

Wiley

Subject

Cellular and Molecular Neuroscience,Neurology

Reference57 articles.

1. Chemokines in autoimmune diseases

2. C10 Is a Novel Chemokine Expressed in Experimental Inflammatory Demyelinating Disorders that Promotes Recruitment of Macrophages to the Central Nervous System

3. Interferon-Independent, Human Immunodeficiency Virus Type 1 gp120-Mediated Induction of CXCL10/IP-10 Gene Expression by Astrocytes In Vivo and In Vitro

4. CCR5+ and CXCR3+ T cells are increased in multiple sclerosis and their ligands MIP-1 and IP-10 are expressed in demyelinating brain lesions

Cited by 102 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. α-Synuclein oligomers potentiate neuroinflammatory NF-κB activity and induce Cav3.2 calcium signaling in astrocytes;Translational Neurodegeneration;2024-02-21

2. Unraveling the neuroimmune interface in chronic pain—the association between cytokines in the cerebrospinal fluid and pain in patients with lumbar disk herniation or degenerative disk disease;Pain;2024-02-05

3. Enhancement of Microglia Functions by Developed Nano‐Immuno‐Synergist to Ameliorate Immunodeficiency for Malignant Glioma Treatment;Advanced Healthcare Materials;2023-09-12

4. Astrocytic response mediated by the CLU risk allele inhibits OPC proliferation and myelination in a human iPSC model;Cell Reports;2023-08

5. Photobiomodulation reduces neuropathic pain after spinal cord injury by downregulating CXCL10 expression;CNS Neuroscience & Therapeutics;2023-07-20